Clinical Significance of Viral Genome Persistence in the Myocardium of Patients with Dilated Cardiomyopathy

Intervirology

Volumn 58, Issue 6, 2016, Pages 350-356

  Nowalany Kozielska, Ewa ^a   Kozieł, Monika ^a   Domal Kwiatkowska, Dorota ^a   Wojciechowska, Celina ^a   Jacheć, Wojciech ^a   Kawecki, Damian ^a   Tomasik, Andrzej ^a   Przywara Chowaniec, Brygida ^a   Wȩglarz, Ludmiła ^a   Reichman Warmusz, Edyta ^a   Wojnicz, Romuald ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Dilated cardiomyopathy; Endomyocardial biopsy; Heart failure; Viral genome

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CONGESTIVE CARDIOMYOPATHY; CORONARY ANGIOGRAPHY; CYTOMEGALOVIRUS; ENTEROVIRUS B; FEMALE; FOLLOW UP; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HISTOCHEMISTRY; HOSPITALIZATION; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS MYOCARDITIS; AGED; BIOPSY; GENETICS; HEART; HEPACIVIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; BIOPSY; CARDIOMYOPATHY, DILATED; CYTOMEGALOVIRUS; DNA, VIRAL; ENTEROVIRUS B, HUMAN; FEMALE; FOLLOW-UP STUDIES; GENOME, VIRAL; HEART; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; PARVOVIRUS B19, HUMAN; VIRUS DISEASES;

EID: 84957654334     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000443375     Document Type: Article

References (23)

1. Elliott P, Andersson B, Arbustini E, et al: Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29: 270-276.
2. McMurray J, Adamopoulos S, Anker S, et al: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 1093:1-61.
3. Dec GW Jr, Palacios IF, Fallon JT, et al: Active myocarditis in the spectrum of acute dilated cardiomyopathies-clinical features, histo-logic correlates, and clinical outcome. N Engl J Med 1985; 312:885-890.
4. Jin O, Sole MJ, Butany JW, et al: Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990; 82:8-16.
5. Caforio AL, Pankuweit S, Arbustini E, et al: Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34:2636-2648.
6. Marholdt H, Wagner A, Deluigi CC, et al: Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006; 114:1581-1590.
7. Schulz JC, Hilliard A, Cooper L Jr, Rihal CS: Diagnosis and treatment of viral myocarditis. Mayo Clin Proc 2009; 84:1001-1009.
8. Andréoletti L, Lévêque N, Boulagnon C, Bras-selet C, Fornes P: Viral causes of human myocarditis. Arch Cardiovasc Dis 2009; 102:559-568.
9. Schonian U, Crombach M, Maser S, Maisch B: Cytomegalovirus-associated heart muscle disease. Eur Heart J 1995; 16:46-49.
10. Kindermann I, Barth C, Mahfoud F, et al: Update on myocarditis. J Am Coll Cardiol 2012; 59:779-792.
11. Aretz HT: Myocarditis: the Dallas criteria. Hum Pathol 1987; 18:619-624.
12. Giacca M, Severini GM, Mestroni L, et al: Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with id-iopathic dilated cardiomyopathy. J Am Coll Cardiol 1994; 24:1033-1040.
13. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al: Detection of adenoviral genome in the myocardium of adult patients with idio-pathic left ventricular dysfunction. Circulation 1999; 99:1348-1354.
14. Archard LC, Khan MA, Soteriou BA, et al: Characterization of Coxsackie B virus RNA in myocardium from patients with dilated car-diomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 1998; 29:578-584.
15. Pankuweit S, Ruppert V, Eckhardt H, Strache D, Maisch B: Pathophysiology and aetiologi-cal diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19. J Vet Med B Infect Dis Vet Public Health 2005; 52:344-347.
16. Why HJ, Meany BT, Richardson PJ, et al: Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardio-myopathy. Circulation 1994; 89:2582-2589.
17. Kindermann I, Kindermann M, Kandolf R, et al: Predictors of outcome in patients with suspected myocarditis. Circulation 2008; 118: 639-648.
18. Caforio AL, Calabrese F, Angelini A, et al: A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aethiopathogentic features at diagnosis. Eur Heart J 2007; 28:1326-1333.
19. Bowles NE, Rose ML, Taylor P, et al: End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 1989; 80:1128-1136.
20. Bock CT, Klingel K, Kandolf R: Human par-vovirus B19-associated myocarditis. N Engl J Med 2010; 362:1248-1249.
21. Martin AB, Webber S, Fricker FJ, et al: Acute myocarditis: rapid diagnosis by PCR in children. Circulation 1994; 90:330-339.
22. Bowles NE, Ni J, Kearney DL, et al: Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003; 42:466-472.
23. Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification. Eur J Echocardiography 2006; 7:79-108.